Psychometric Evaluation of the Diabetes Symptom Checklist-Revised (DSC-R)—A Measure of Symptom Distress
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 12 (8) , 1168-1175
- https://doi.org/10.1111/j.1524-4733.2009.00571.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Adding Insulin Glargine Versus RosiglitazoneDiabetes Care, 2007
- Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetesHealth and Quality of Life Outcomes, 2006
- Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening studyQuality of Life Research, 2005
- Health‐related quality of life in the first year following diagnosis of Type 2 diabetes: newly diagnosed patients in general practice compared with screening‐detected patients. The Hoorn Screening StudyDiabetic Medicine, 2004
- The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study*Current Medical Research and Opinion, 2004
- Quality of life and diabetesDiabetes/Metabolism Research and Reviews, 1999
- Well-Being and Symptoms in Relation to Insulin Therapy in Type 2 DiabetesDiabetes Care, 1998
- Symptoms and Well-Being in Relation to Glycemic Control in Type II DiabetesDiabetes Care, 1996
- Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitusDiabetes Research and Clinical Practice, 1994
- Development of a Type 2 Diabetes Symptom Checklist: a Measure of Symptom SeverityDiabetic Medicine, 1994